Key facts
- Leadoptik’s last known valuation is $21.3M (Sep 2025).
- It has raised $11.4M across 2 recorded rounds; the latest was Seed Round ($4.6M) in Aug 2025.
- Notable investors include Creative Destruction Lab, SOSV, MedTech Innovator, University of Toronto, HAX — 13 tracked in total.
- Leadoptik has filed 2 Form Ds with the SEC since 2023, most recently Sep 2025 ($4.6M sold to 13 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Leadoptik
Funding rounds
2 roundsAbout Leadoptik
Developer of a miniature imaging technology intended for minimally invasive procedures. The company helps surgeons view smaller objects and the current imaging systems with three-dimensional navigation capability and elevated-resolution imaging in fundamental time, enabling surgeons to detect early stages of cancer in patients.
- Sector
- Healthcare
- HQ
- San Jose, CA, United States
- Founded
- 2020
- Employees
- 15
- Website
- leadoptik.com/
- Ownership
- Privately Held (backing)
Leadoptik doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Leadoptik shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Leadoptik in its N-PORT filings yet. We sweep new filings monthly.